Gevo, Inc. (GEVO)
-NasdaqGM | Prev Close: | 1.84 |
|---|
| Open: | N/A |
|---|
| Bid: | 1.64 x 500 |
|---|
| Ask: | 1.99 x 5000 |
|---|
| 1y Target Est: | 6.00 |
|---|
| Beta: | 4.21 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 1.36 - 9.44 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,148,470 |
|---|
| Market Cap: | 78.85M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.65 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Best Stocks to Invest in Industrial Biotechat Motley Fool(Sun, 19 May)
- Gevo to Present at the Cowen Technology, Media & Telecommunications ConferenceGlobeNewswire(Thu, 16 May)
- Butamax, NIH, Redskins, Righthaven: Intellectual Propertyat Bloomberg(Mon, 13 May)
- This Bill Wants to Cut Ethanol Production in Halfat Motley Fool(Sat, 11 May)
- GEVO, INC. FinancialsEDGAR Online Financials(Sat, 11 May)
- Butamax and Gevo Grapple With Biofuels Patent Case Claimsat Bloomberg(Sat, 11 May)
- Gevo Temporarily Dismisses GIFT(R) Lawsuit Because Butamax Does Not Have a Commercial Biobutanol PlantGlobeNewswire(Fri, 10 May)
- Court dismisses all claims in Gevo case against Butamaxtheflyonthewall.com(Fri, 10 May)
- GEVO, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, 6 May)
- IPO Preview: BioAmberat Seeking Alpha(Fri, 3 May)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.04 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.46 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.35 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | -0.05 |
|---|
Business Summary
Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks.
View More